Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8504)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2015 (publication date) through May 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu Y, Zhang YG, Wang X, Qi WQ, Qin SY, Liu ZH, Jiao J, Wang JB. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis. World J Gastroenterol 2015; 21(25): 7869-7876 [PMID: 26167087 DOI: 10.3748/wjg.v21.i25.7869] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i25/7869.htm |
| Number | Citing Articles |
| 1 |
Byung Gyu Kim, Neung Hwa Park, Seung Bum Lee, Hojune Lee, Byung Uk Lee, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung‐Jo Bang, Jung Woo Shin. Mortality, liver transplantation and hepatic complications in patients with treatment‐naïve chronic hepatitis B treated with entecavir vs tenofovir. Journal of Viral Hepatitis 2018; 25(12): 1565 doi: 10.1111/jvh.12971
|
| 2 |
Julien Marlet, Clément Lier, Emmanuelle Roch, Alain Moreau, Benjamin Combe, Lynda Handala, Sandrine Lefeuvre, Morgan Maugey, Laure Elkrief, Louis d’Alteroche, Pascal Potier, Denys Brand, Catherine Gaudy-Graffin. Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure. Antiviral Research 2021; 192: 105106 doi: 10.1016/j.antiviral.2021.105106
|
| 3 |
Xiao-Dong Gai, Wei-Feng Wu. Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis. Experimental and Therapeutic Medicine 2017; 14(4): 3908 doi: 10.3892/etm.2017.4963
|
| 4 |
P. Lampertico, H. L. Y. Chan, H. L. A. Janssen, S. I. Strasser, R. Schindler, T. Berg. Review article: long‐term safety of nucleoside and nucleotide analogues in HBV‐monoinfected patients. Alimentary Pharmacology & Therapeutics 2016; 44(1): 16 doi: 10.1111/apt.13659
|
| 5 |
Julien Marlet, Clément Lier, Emmanuelle Roch, Morgan Maugey, Alain Moreau, Benjamin Combe, Sandrine Lefeuvre, Louis d’Alteroche, Didier Barbereau, Xavier Causse, Frédéric Bastides, Marie-Nadege Bachelier, Denys Brand, Catherine Gaudy-Graffin. Revisiting HBV resistance to entecavir with a phenotypic approach. Antiviral Research 2020; 181: 104869 doi: 10.1016/j.antiviral.2020.104869
|
| 6 |
Lin Wang, Yiqi Liu, Qixin Gu, Chi Zhang, Lei Xu, Lei Wang, Cuiying Chen, Xueen Liu, Hong Zhao, Hui Zhuang. Serum N-Glycan Markers for Diagnosing Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels. Engineering 2023; 26: 151 doi: 10.1016/j.eng.2023.03.008
|
| 7 |
Hui Zheng, Guomin Zhang, Fuzhen Wang, Zundong Yin, Ning Miao, Xiaojin Sun, Xiaofeng Liang, Fuqiang Cui. Self-motivated medical care-seeking behaviors and disease progression in a community-based cohort of chronic hepatitis B virus-infected patients in China. BMC Public Health 2019; 19(1) doi: 10.1186/s12889-019-7061-1
|
| 8 |
Mar Riveiro-Barciela, David Tabernero, José L. Calleja, Sabela Lens, María L. Manzano, Francisco Gea Rodríguez, Javier Crespo, Belén Piqueras, Juan M. Pascasio, Carmen Comas, Maria L. Gutierrez, Alberto Aguirre, Emilio Suárez, Javier García-Samaniego, Miguel Rivero, Doroteo Acero, Miguel Fernandez-Bermejo, Diego Moreno, Pilar Sánchez-Pobre, Beatriz de Cuenca, J. J Moreno-Palomares, Rafael Esteban, Maria Buti. Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma. Digestive Diseases and Sciences 2017; 62(3): 784 doi: 10.1007/s10620-017-4448-7
|
| 9 |
Rui Zhang, Peixia Li, Pengpeng Guo, Jinping Zhou, Jing Wan, Chunxiao Yang, Jiali Zhou, Yani Liu, Shaojun Shi. A Pharmacokinetic Drug–Drug Interactions Study between Entecavir and Hydronidone, a Potential Novel Antifibrotic Small Molecule, in Healthy Male Volunteers. Advances in Therapy 2023; 40(2): 658 doi: 10.1007/s12325-022-02377-x
|
| 10 |
Jiancun Hou, Zhe Qiang, Yang Li, Yamin Zhang. The Different Prognoses of Hepatocellular Carcinoma with Previous Tenofovir versus Entecavir Treatment for Chronic Hepatitis B Virus: Analysis Based on 15 Propensity Score-Matched Studies. Digestive Diseases 2023; 41(3): 476 doi: 10.1159/000528711
|
| 11 |
Hye Won Lee, Jun Yong Park, Sang Hoon Ahn. An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 177 doi: 10.1586/17474124.2016.1125781
|
| 12 |
Ali Asan, Murat Sayan, Sila Akhan, Suda Tekin Koruk, Bilgehan Aygen, Fatma Sirmatel, Haluk Eraksoy, Nazan Tuna, Sukran Köse, Ali Kaya, Necla Eren Tulek, Nazlim Aktug Demir, Resit Mistik, Bahar Ormen, Fatime Korkmaz, Taner Yildirmak, Onur Ural, Mehtap Aydin, Huseyin Turgut, Ozgur Gunal, Nese Demirturk. Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Patients with Chronical Infection in Turkey. Hepatitis Monthly 2018; 18(1) doi: 10.5812/hepatmon.12472
|
| 13 |
Hong Zhao, Qi Wang, Changling Luo, Ligai Liu, Wen Xie. Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9609731
|
| 14 |
Mingyang Feng, Kehui Liu, Gangde Zhao, Shike Lou, Baoyan An, Lanyi Lin, Yezhou Ding, Shisan Bao, Hui Wang. A novel model based on qAnti-HBc and conventional biomarkers for identifying significant liver injury among CHB patients with ALT ≤ ULN. Antiviral Research 2022; 202: 105315 doi: 10.1016/j.antiviral.2022.105315
|
| 15 |
Guiqiang Wang, Zhongping Duan. Guidelines for Prevention and Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00209
|
| 16 |
Jun Li, Xiao-Qin Dong, Li-Hua Cao, Zhan-Qing Zhang, Wei-Feng Zhao, Qing-Hua Shang, Da-Zhi Zhang, An-Lin Ma, Qing Xie, Hong-Lian Gui, Guo Zhang, Ying-Xia Liu, Jia Shang, Shi-Bin Xie, Yi-Qi Liu, Chi Zhang, Gui-Qiang Wang, Hong Zhao. Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1151899
|
| 17 |
Xiaoling Chi, Huanming Xiao, Meijie Shi, Gaoshu Cai, Yubao Xie, Junmin Jiang, Guangjun Tian, Shuduo Wu, Chaozhen Zhang, Pengtao Zhao, Jiezhen Chen. Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1005-1
|
| 18 |
Lihu Gu, Qigu Yao, Zefeng Shen, Ying He, Derry Minyao Ng, Tong Yang, Bangsheng Chen, Ping Chen, Feiyan Mao, Qili Yu. Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2020; 35(9): 1467 doi: 10.1111/jgh.15036
|
| 19 |
Sihui Zhang, Chao Wang, Bei Liu, Qing-Bin Lu, Jia Shang, Yihua Zhou, Jidong Jia, Xiaoyuan Xu, Huiying Rao, Bingfeng Han, Tianshuo Zhao, Linyi Chen, Mingzhu Xie, Jiahao Cui, Juan Du, Jing zeng, Ninghua huang, Yaqiong Liu, Lei Zhang, Hui Zhuang, Fuqiang Cui. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation. The Lancet Regional Health - Western Pacific 2023; 35: 100738 doi: 10.1016/j.lanwpc.2023.100738
|